Cabozantinib routine ‘beat the doublet in PFS’ in untreated superior kidney most cancers March 22, 2023 Doublet
XL092 Plus Atezolizumab Vs Regorafenib Underneath Investigation in MSS_MSI-Low mCRC March 18, 2023 Doublet